Green Preparation Process, Characterization and Antitumor Effects of Doxorubicin-BSA-Dextran Nanoparticles

被引:53
作者
Deng, Wei [1 ,2 ]
Li, Juan [1 ,2 ]
Yao, Ping [1 ,2 ]
He, Fen [3 ]
Huang, Chong [3 ]
机构
[1] Fudan Univ, Key Lab Mol Engn Polymer, Shanghai 200433, Peoples R China
[2] Fudan Univ, Dept Macromol Sci, Shanghai 200433, Peoples R China
[3] Natl Pharmaceut Engn Res Ctr, Shanghai 201203, Peoples R China
基金
中国国家自然科学基金;
关键词
albumin; dextran; doxorubicin; drug delivery system; nanoparticles; BOVINE SERUM-ALBUMIN; TARGETED DRUG-DELIVERY; PROTEIN NANOPARTICLES; CREMOPHOR-FREE; CARDIOTOXICITY; NANOSPHERES; FORMULATION; PACLITAXEL; COPOLYMERS; MICELLES;
D O I
10.1002/mabi.201000125
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In this report, we developed a simple and green process of simultaneous formation of doxorubicin-BSA-dextran nanoparticles in aqueous solution and high-effective encapsulation of doxorubicin. In the presence of BSA-dextran conjugates, which were produced by Maillard reaction, a binding of doxorubicin with BSA can suppress the self-aggregation of unprotonated doxorubicin. After a heat treatment, the gelation of BSA results in a formation of the nanoparticles and the doxorubicin was fixed inside the nanoparticles. The dextran shell makes the nanoparticles dispersible in solution. The nanoparticles have a spherical morphology and a hydrodynamic radius of about 90 nm. Importantly, the nanoparticles can significantly prolong the life of murine ascites hepatoma H22 tumor-bearing mice.
引用
收藏
页码:1224 / 1234
页数:11
相关论文
共 38 条
  • [1] Drug delivery systems: Entering the mainstream
    Allen, TM
    Cullis, PR
    [J]. SCIENCE, 2004, 303 (5665) : 1818 - 1822
  • [2] Design of environment-sensitive supramolecular assemblies for intracellular drug delivery: Polymeric micelles that are responsive to intracellular pH change
    Bae, Y
    Fukushima, S
    Harada, A
    Kataoka, K
    [J]. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2003, 42 (38) : 4640 - 4643
  • [3] Interactions involved in the gelation of bovine serum albumin
    Boye, JI
    Alli, I
    Ismail, AA
    [J]. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 1996, 44 (04) : 996 - 1004
  • [4] Doxorubicin: The Good, the Bad and the Ugly Effect
    Carvalho, Cristina
    Santos, Renato X.
    Cardoso, Susana
    Correia, Sonia
    Oliveira, Paulo J.
    Santos, Maria S.
    Moreira, Paula I.
    [J]. CURRENT MEDICINAL CHEMISTRY, 2009, 16 (25) : 3267 - 3285
  • [5] Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of Cremophor-free, albumin-bound paclitaxel, ABI-007, compared with Cremophor-based paclitaxel
    Desai, N
    Trieu, V
    Yao, ZW
    Louie, L
    Ci, S
    Yang, A
    Tao, CL
    De, T
    Beals, B
    Dykes, D
    Noker, P
    Yao, R
    Labao, E
    Hawkins, M
    Soon-Shiong, P
    [J]. CLINICAL CANCER RESEARCH, 2006, 12 (04) : 1317 - 1324
  • [6] EMULSIFYING PROPERTIES OF COVALENT PROTEIN DEXTRAN HYBRIDS
    DICKINSON, E
    SEMENOVA, MG
    [J]. COLLOIDS AND SURFACES, 1992, 64 (3-4): : 299 - 310
  • [7] Preparation, characterisation and maintenance of drug efficacy of doxorubicin-loaded human serum albumin (HSA) nanoparticles
    Dreis, S.
    Rothweller, F.
    Michaelis, A.
    Cinatl, J., Jr.
    Kreuter, J.
    Langer, K.
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2007, 341 (1-2) : 207 - 214
  • [8] PROTEIN GELS
    FERRY, JD
    [J]. ADVANCES IN PROTEIN CHEMISTRY, 1948, 4 : 1 - 78
  • [9] BIODEGRADABLE LONG-CIRCULATING POLYMERIC NANOSPHERES
    GREF, R
    MINAMITAKE, Y
    PERACCHIA, MT
    TRUBETSKOY, V
    TORCHILIN, V
    LANGER, R
    [J]. SCIENCE, 1994, 263 (5153) : 1600 - 1603
  • [10] Protein nanoparticles as drug carriers in clinical medicine
    Hawkins, Michael J.
    Soon-Shiong, Patrick
    Desai, Neil
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2008, 60 (08) : 876 - 885